Search

Displaying results 2491 - 2500 of 3601 in total

Drug
Lefetamine
go.drugbank.com/drugs/DB19944
Experimental
Lefetamine is a small molecule drug. Lefetamine has a monoisotopic molecular weight of 225.15 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
Drug
Tauromustine
go.drugbank.com/drugs/DB19978
Experimental
Tauromustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Tauromustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative. Tauromustine has a monoisotopic molecular weight...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
Cloperidone
go.drugbank.com/drugs/DB20327
Experimental
Cloperidone is a small molecule drug. Cloperidone has a monoisotopic molecular weight of 398.15 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 Inhibitors
Drug
Mofarotene
go.drugbank.com/drugs/DB20333
Experimental
Mofarotene is a small molecule drug. The usage of the INN stem '-arotene' in the name indicates that Mofarotene is a arotinoid derivative. Mofarotene has a monoisotopic molecular weight of 433.3 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
Navamepent
go.drugbank.com/drugs/DB21096
Investigational
Navamepent is a small molecule drug. Navamepent is under investigation in clinical trial NCT02329743 (Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery). Navamepent has a monoisotopi...
Categories: P-glycoprotein inhibitors
Drug
Sevabertinib
go.drugbank.com/drugs/DB21667
ApprovedInvestigational
[L54638] Sevabertinib functions as a reversible kinase inhibitor of human epidermal growth factor receptor 2 (HER2), also exhibiting activity against epidermal growth factor receptor (EGFR).
Categories: P-glycoprotein inhibitors, P-glycoprotein substrates
Drug
Daraxonrasib
go.drugbank.com/drugs/DB22308
ApprovedInvestigational
Daraxonrasib is an orally administered, multi-selective inhibitor of the RAS GTPase family used to treat metastatic pancreatic adenocarcinoma. It is a RAS(ON) tri-complex inhibitor that binds cyclophilin A and targets the active, GTP-bou...
Categories: P-glycoprotein inhibitors, P-glycoprotein substrates
Drug
Ergoloid mesylate
go.drugbank.com/drugs/DB01049
Approved
Ergoloid Mesylate is an equiproportional preparation of three different ergotamantriones: dihydroergocornine, dihydroergocristine, and dihydroergocryptine. All these components are produced by the fungus Claviceps purpurea and are all de...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
Gliclazide
go.drugbank.com/drugs/DB01120
ApprovedInvestigational
Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic β cell receptor.
Synonyms: 1-(3-azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)ureaCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 Substrates
Drug
Light green SF yellowish
go.drugbank.com/drugs/DB11183
Approved
Light green SF yellowish is a green triarylmethane dye that is used in the preparation of the staining solution which is widely used as a counterstain. It is used in histological applications and other labratory settings, and usually exi...
Categories: P-glycoprotein inhibitors